These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2876744)

  • 61. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
    Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
    Gut; 1988 May; 29(5):669-74. PubMed ID: 2899536
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sulfasalazine in the rheumatic disease.
    Pinals RS
    Semin Arthritis Rheum; 1988 May; 17(4):246-59. PubMed ID: 2906760
    [No Abstract]   [Full Text] [Related]  

  • 63. Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study.
    Farr M; Kitas GD; Waterhouse L; Jubb R; Felix-Davies D; Bacon PA
    Br J Rheumatol; 1990 Feb; 29(1):46-9. PubMed ID: 1968355
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of the seronegative spondyloarthropathies with sulfasalazine.
    Zwillich SH; Comer SS; Lee E; Erdman WA; Lipsky PE
    J Rheumatol Suppl; 1988 Sep; 16():33-9. PubMed ID: 2903925
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
    Dougados M; Béhier JM; Jolchine I; Calin A; van der Heijde D; Olivieri I; Zeidler H; Herman H
    Arthritis Rheum; 2001 Jan; 44(1):180-5. PubMed ID: 11212158
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Persistence of enthesopathic changes in patients with spondylarthropathy during a 6-month follow-up.
    Lehtinen A; Leirisalo-Repo M; Taavitsainen M
    Clin Exp Rheumatol; 1995; 13(6):733-6. PubMed ID: 8835246
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.
    van Denderen JC; van der Paardt M; Nurmohamed MT; de Ryck YM; Dijkmans BA; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2005 Dec; 64(12):1761-4. PubMed ID: 15901634
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis.
    Haibel H; Specker C
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S159-63. PubMed ID: 19822065
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Treatment of juvenile spondylarthritis and reactive arthritis with sulfasalazine].
    Suschke HJ
    Monatsschr Kinderheilkd; 1992 Sep; 140(9):658-60. PubMed ID: 1359405
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial.
    Gonzalez-Lopez L; Garcia-Gonzalez A; Vazquez-Del-Mercado M; Muñoz-Valle JF; Gamez-Nava JI
    J Rheumatol; 2004 Aug; 31(8):1568-74. PubMed ID: 15290737
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Associations between inflammation, nocturnal back pain and fatigue in ankylosing spondylitis and improvements with etanercept therapy.
    Hammoudeh M; Zack DJ; Li W; Stewart VM; Koenig AS
    J Int Med Res; 2013 Aug; 41(4):1150-9. PubMed ID: 23803306
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical study on treatment of patients with ankylosing spondylitis by Panlongqi tablet].
    Zhao FT; Zhao H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jun; 27(6):540-2. PubMed ID: 17633369
    [TBL] [Abstract][Full Text] [Related]  

  • 73. T lymphocytes in ankylosing spondylitis and the influence of sulphasalazine treatment.
    Feltelius N; Hällgren R; Sjöberg O
    Clin Rheumatol; 1987 Dec; 6(4):545-52. PubMed ID: 2896558
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Pirprofen, indomethacin and placebo in ankylosing spondylitis. Double-blind comparison].
    Jajic I; Nekora A; Chadri HA
    Nouv Presse Med; 1982 Aug; 11(33):2491-3. PubMed ID: 6752873
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ximoprofen in ankylosing spondylitis. A double blind placebo controlled dose ranging study.
    Dougados M; Nguyen M; Caporal R; Legeais J; Bouxin-Sauzet A; Pellegri-Guegnault B; Gomeni C
    Scand J Rheumatol; 1994; 23(5):243-8. PubMed ID: 7973477
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Etanercept: in ankylosing spondylitis.
    McCormack PL; Wellington K
    BioDrugs; 2004; 18(3):199-205; discussion 206. PubMed ID: 15161337
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Clinical evaluation of tenoxicam in osteoarthrosis, rheumatoid arthritis and ankylosing spondylitis.
    Standel W; Josenhants G
    Eur J Rheumatol Inflamm; 1985; 8(1):28-38. PubMed ID: 3915885
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Are there any antirheumatic drugs that modify the course of ankylosing spondylitis?
    Laurent R
    Baillieres Clin Rheumatol; 1990 Aug; 4(2):387-400. PubMed ID: 1674450
    [No Abstract]   [Full Text] [Related]  

  • 79. Meclofenamate sodium in the treatment of ankylosing spondylitis. Report of a European double-blind controlled multicenter study.
    Ebner W; Poal Ballarin JM; Boussina I
    Arzneimittelforschung; 1983; 33(4A):660-3. PubMed ID: 6349653
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is sulfasalazine effective in ankylosing spondylitis? A systematic review of randomized controlled trials.
    Chen J; Liu C
    J Rheumatol; 2006 Apr; 33(4):722-31. PubMed ID: 16583475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.